MI Visit the ASPET Website
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Molecular Interventions 8:162-164, (2008)
© American Society for Pharmacology and Experimental Therapeutics
10.1124/mi.8.4.5
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Cmarik, J. L.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cmarik, J. L.

Viewpoint

From Bioinformatics to Bioassays: Gleaning Insights into Protein Structure-Function from Disease-Associated nsSNPs

Joan L. Cmarik

Laboratory of Cancer Prevention, Center for Cancer Research, National Cancer Institute–Frederick, National Institutes of Health, Frederick, MD 21702-1201

SUMMARY

Non-synonymous single nucleotide polymorphisms (SNPs) that result in amino acid sub-stitutions may have no appreciable effect on protein function, but those that involve critical residues may cause or contribute to disease. Large-scale gene sequencing studies have revealed a daunting number of non-synonymous SNPs with unknown functional consequences. Both predictive techniques and functional assays can aid in the identification of disease-relevant SNPs, as illustrated by two recent reports. An insightful comparison of known disease-causing vs uncharacterized SNPs in protein kinases sheds new light on regions of the catalytic core. The observed prevelance of disease-causing SNPs in substrate binding and regulatory regions––but paucity thereof in residues directly involved in the catalytic reaction––will likely extend to other enzymes as well. A clever functional bioassay using mouse ES cells distinguishes neutral from deleterious mutations in the breast and ovarian cancer-related BRCA2 gene, which may aid in the interpretation of patient BRCA2 screening data.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ASPET Journals Pharmacological Reviews Drug Metabolism and Disposition
Molecular Interventions Molecular Pharmacology J Pharmacology and Exp Therapeutics
Copyright © 2008 by the American Society for Pharmacology and Experimental Therapeutics.